Changhai Hospital

Running trials

• Not yet recruiting

  A Study of T-DXd in AI-Assessed HER2-Ultralow Metastatic Breast Cancer

  NCT07782086· Source

• Not yet recruiting

  Savolitinib Plus Cetuximab and FOLFOX Chemotherapy for RAS/BRAF Wild-type Metastatic Colorectal Cancer

  NCT07683403· Phase 1/2· Source

• Recruiting

  SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis

  NCT07384234· Phase 2· Source

• Recruiting

  AI-Powered Precision Decision-Making for Pancreatic Diseases

  NCT07439757· Source

• Recruiting

  Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

  NCT07246096· Early phase 1· Source

• Recruiting

  CAR-NK Cells (CL-NK-003) in Pancreatic Cancer

  NCT07425483· Phase 1· Source

• Recruiting

  A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure

  NCT07265349· Phase 1/2· Source

• Recruiting

  Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration

  NCT07307456· Phase 2· Source

• Recruiting

  Prevention of Atrial Fibrillation After Cardiac Surgery by Pericardiotomy

  NCT06728826· Source

• Recruiting

  Investigation Into the Integration of Intracavitary Cryoablation and Immunotherapy in Bladder-Preserving Therapy

  NCT07204132· Source

• Active, not recruiting

  Neoadjuvant Chemotherapy Before Surgery vs Surgery Alone for UTUC: A Randomized Trial

  NCT07492225· Phase 2· Source

• Recruiting

  Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer

  NCT07117045· Source

• Not yet recruiting

  Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial Carcinoma

  NCT06927128· Phase 2· Source

• Recruiting

  CAR-NK Cells (CL-NK-001) in Pancreatic Cancer

  NCT06816823· Phase 1· Source

• Recruiting

  HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients

  NCT06885710· Phase 1· Source

• Active, not recruiting

  Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer

  NCT06693128· Phase 2· Source

• Recruiting

  AI-Assisted Non-Contrast CT for Multi-Cancer Screening

  NCT06632886· Source

• Recruiting

  Radical Hypofractionated Radiotherapy for Localized Prostate Cancer

  NCT06325774· Source

• Not yet recruiting

  Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria

  NCT06469229· Source

• Active, not recruiting

  A Comparative Study of Neoadjuvant Chemotherapy Versus Upfront Radical Surgery for Upper Tract Urothelial Carcinoma

  NCT07155044· Source

• Not yet recruiting

  A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)

  NCT06340490· Phase 1· Source

• Recruiting

  Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer

  NCT06346093· Source

• Recruiting

  Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer

  NCT06325995· Source

• Recruiting

  A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)

  NCT06210776· Source

• Recruiting

  Safety and Efficacy of OCN19-overexpressed Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Refractory Type 2 Diabetes Mellitus

  NCT06727721· Phase 2· Source

• Recruiting

  An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus

  NCT06010472· Early phase 1· Source

• Recruiting

  Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic Carcinoma

  NCT05869474· Source

• Recruiting

  Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture

  NCT05866029· Source

• Recruiting

  Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples

  NCT05737953· Source

• Active, not recruiting

  Effects of Hemodialysis Plus Hemoperfusion in Maintenance Hemodialysis Patients: A Clinical Study

  NCT05639010· Source

• Recruiting

  Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer

  NCT04146298· Phase 1/2· Source

• Not yet recruiting

  Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

  NCT04995159· Source

• Recruiting

  Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

  NCT04527861· Source

• Recruiting

  Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial

  NCT05053802· Phase 2· Source

• Not yet recruiting

  Colorectal Adenoma Canceration in FAP

  NCT04531930· Source

• Recruiting

  Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer

  NCT04270591· Phase 1/2· Source

• Active, not recruiting

  Association Between Carotid Plaque Length and Cardiovascular Events

  NCT05159804· Source

• Active, not recruiting

  Carotid Plaque Length to Predict Cardiovascular Events

  NCT05409209· Source

• Active, not recruiting

  Association Between Carotid Plaque Length and Cardiovascular Outcomes

  NCT05843487· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Pancreatic cancer8 recruiting
• Bladder cancer4 recruiting
• Colorectal cancer4 recruiting
• Gastric and esophageal cancer3 recruiting
• Lung cancer3 recruiting
• Lupus (SLE)3 recruiting
• Metastatic breast cancer2 recruiting
• Prostate cancer2 recruiting
• ANCA-associated vasculitis1 recruiting
• Atrial fibrillation1 recruiting
• Childhood cancers1 recruiting
• Coronary artery disease1 recruiting
• Heart failure1 recruiting
• Hepatitis B1 recruiting
• Liver and biliary tract cancer1 recruiting
• Neuroendocrine tumours1 recruiting
• Osteoporosis1 recruiting
• Rheumatoid arthritis1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Prediction Model of Pancreatic Neoplasms in CP Patients With Focal Pancreatic Lesions

  NCT07045181· Source

• Completed

  The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis

  NCT06589154· Source

• Terminated

  A Study of Surufatinib as Adjuvant Therapy for Pancreatic Neuroendocrine Tumors

  NCT06158516· Phase 2· Source

• Completed

  Statin Addition to Chemotherapy for Advanced Pancreatic Cancer

  NCT06241352· Phase 2· Source

• Completed

  Comprehensive Management of High-risk PopuLatIon for Stroke Based on Social Network

  NCT05963828· Source

• Completed

  rTMS Combined With Motor Training for the Treatment of Upper Limb Motor Dysfunction in Stroke Patients

  NCT06752499· Source

• Completed

  Large Artery Occlusion Treated in Extended Time With Mechanical Thrombectomy Trial

  NCT05326932· Source

• Completed

  Laparoscopic-assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy for Gastric Cancer

  NCT05541783· Source

• Completed

  Organoid-Guided Adjuvant Chemotherapy for Pancreatic Cancer

  NCT04931394· Phase 3· Source

• Completed

  Different Patterns of Target Delineation in SBRT for Locally Advanced Pancreatic Cancer

  NCT04699539· Source

• Completed

  Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses

  NCT04603586· Source

• Completed

  Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

  NCT04085276· Phase 3· Source

• Completed

  XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)

  NCT03399110· Phase 3· Source